ANRESIS, the Swiss Centre for Antibiotic Resistance, is a nationwide, representative surveillance system and research platform for antibiotic resistance and consumption. It is hosted by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.

ANRESIS continuously collects all anonymised resistance data generated in routine diagnostics by over 35 human medical laboratories and 10 veterinary laboratories, as well as antibiotic consumption data from more than 45 hospital pharmacies.

ANRESIS provides processed and aggregated data to the public, as well as to authorities, hospitals, physicians and interested academic researchers. Data from individual hospitals are not published (privacy statement).

ANRESIS has a modular, flexible structure and is continually being developed. Additional modules include the monitoring of bacteremia and the monitoring of Clostridium difficile infections.

ANRESIS is an important pillar in the struggle against the growing problem of antibiotic resistance. As part of the National Strategy on Antibiotic Resistance (StAR), it has broad support within Switzerland and is well-connected internationally (see links resistance and consumption).

ANRESIS continuously collects anonymised resistance and use data from
> 35
Laboratories for human medicine
10
Laboratories for veterinary medicine
> 45
Hospital pharmacies
> 1000
Pharmacies